Concepedia

Publication | Open Access

Five-year results of patients supported by HeartMate II: outcomes and adverse events

26

Citations

25

References

2017

Year

Abstract

This is the first single-cohort study to describe a 5-year survival of HMII patients on extended duration of support. A 5-year survival of 54% was observed in this single-centre cohort.

References

YearCitations

Page 1